Pharmagreen Biotech Inc. (PHBI)
USD 0.0
(-11.76%)
USD 0.0
(-11.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -73.83 Thousand | -426.56 Thousand | -206.08 Thousand | -607.63 Thousand | -317.83 Thousand | -785.53 Thousand |
| Net Income | -568.77 Thousand | -875.5 Thousand | -4.53 Million | -2.43 Million | -768.81 Thousand | -1.07 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 76.37 Thousand | 461.03 Thousand | 627.67 Thousand | 10.78 Thousand | 172.5 Thousand | - |
| Change in working capital | 211.13 Thousand | 242.67 Thousand | -89.69 Thousand | -63.08 Thousand | 155.52 Thousand | -36.81 Thousand |
| Other non-cash items | 207.43 Thousand | -254.76 Thousand | 3.78 Million | 1.88 Million | 122.95 Thousand | 324.86 Thousand |
| Investing Cash Flow | - | - | - | - | -196.12 Thousand | -251.31 Thousand |
| Investments in PPE | -2.00 | - | - | - | -196.12 Thousand | -251.31 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -196.12 Thousand | - |
| Financing Cash Flow | 83.37 Thousand | 313.7 Thousand | 257.49 Thousand | 562.62 Thousand | 432.82 Thousand | 1.12 Million |
| Debt repayment | -83.37 Thousand | -14.84 Thousand | -43.88 Thousand | -168.54 Thousand | -59.35 Thousand | -104.25 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 187 Thousand | 267.72 Thousand | 40 Thousand | 390.00 | - |
| Other Financing Activities | - | 141.55 Thousand | 33.65 Thousand | 691.16 Thousand | 491.79 Thousand | 1.22 Million |
| Accounts receivables | -225.00 | -93.00 | 5.00 | 10.34 Thousand | 21.12 Thousand | -28.57 Thousand |
| Accounts payables | - | 65.43 Thousand | 147.65 Thousand | -16.22 Thousand | 231.08 Thousand | 18.37 Thousand |
| Inventory | -8774.00 | - | -5.00 | -10.34 Thousand | -21.12 Thousand | - |
| Other working capital | 220.13 Thousand | 177.32 Thousand | -237.34 Thousand | -46.86 Thousand | -75.55 Thousand | -55.19 Thousand |
| Cash at beginning of period | 8016.00 | 25.3 Thousand | 12.19 Thousand | 62.68 Thousand | 151.86 Thousand | 16.44 Thousand |
| Cash at end of period | 1254.00 | 8016.00 | 25.3 Thousand | 12.19 Thousand | 62.68 Thousand | 151.86 Thousand |
| Capital Expenditure | -2.00 | - | - | - | -196.12 Thousand | -251.31 Thousand |
| Effect of forex changes on cash | -16.29 Thousand | 95.57 Thousand | -38.31 Thousand | -5472.00 | -8056.00 | 49.63 Thousand |
| Net cash flow / Change in cash | -6762.00 | -17.28 Thousand | 13.1 Thousand | -50.48 Thousand | -89.18 Thousand | 135.42 Thousand |
| Free Cash Flow | -73.84 Thousand | -426.56 Thousand | -206.08 Thousand | -607.63 Thousand | -513.95 Thousand | -1.03 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -42.52 Thousand | -37.95 Thousand | -144.85 Thousand | -568.77 Thousand | -178.51 Thousand | -162.93 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 76.37 Thousand | - | - |
| Change in working capital | 68.47 Thousand | 55.28 Thousand | 74.18 Thousand | 351.71 Thousand | 66.89 Thousand | 97.17 Thousand |
| Other non-cash items | -26.76 Thousand | -44 Thousand | 68.44 Thousand | 152.22 Thousand | 83.56 Thousand | 73.26 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 5.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 521.00 | 28.03 Thousand | - | 83.37 Thousand | -589.00 | 17.69 Thousand |
| Debt repayment | -521.00 | -28.03 Thousand | - | -83.37 Thousand | -589.00 | -17.69 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 28.03 Thousand | - | - | - | 17.69 Thousand |
| Accounts receivables | 7.00 | 14.00 | 11.00 | -225.00 | -2.00 | -37.00 |
| Accounts payables | - | - | - | - | - | 42.77 Thousand |
| Inventory | 154.00 | 148.00 | 223.00 | -8774.00 | 473.00 | 296.00 |
| Other working capital | 36.99 Thousand | 55.12 Thousand | 73.95 Thousand | 360.71 Thousand | 66.41 Thousand | 54.14 Thousand |
| Cash at beginning of period | 560.00 | 743.00 | 1254.00 | 8016.00 | 5315.00 | 7386.00 |
| Cash at end of period | 246.00 | 560.00 | 743.00 | 1254.00 | 1254.00 | 5315.00 |
| Capital Expenditure | 5.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | -1704.00 | 1472.00 | -16.29 Thousand | 24.11 Thousand | -27.27 Thousand |
| Net cash flow / Change in cash | -314.00 | -183.00 | -511.00 | -6762.00 | -4061.00 | -2071.00 |
| Free Cash Flow | -650.00 | -26.51 Thousand | -1983.00 | -73.83 Thousand | -27.58 Thousand | 7512.00 |
0OQX
FERL
SLS
RDG
SMTI
0672